- Home
- STTK vs LVLU Comparison
STTK vs LVLU Comparison
Compare STTK & LVLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- LVLU
- Stock Information
- Founded
- STTK 2016
- LVLU 1996
- Country
- STTK United States
- LVLU United States
- Employees
- STTK N/A
- LVLU N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- LVLU Catalog/Specialty Distribution
- Sector
- STTK Health Care
- LVLU Consumer Discretionary
- Exchange
- STTK Nasdaq
- LVLU Nasdaq
- Market Cap
- STTK 56.8M
- LVLU 47.5M
- IPO Year
- STTK 2020
- LVLU 2021
- Fundamental
- Price
- STTK $1.11
- LVLU $0.93
- Analyst Decision
- STTK Hold
- LVLU Hold
- Analyst Count
- STTK 3
- LVLU 3
- Target Price
- STTK $2.00
- LVLU $1.58
- AVG Volume (30 Days)
- STTK 172.1K
- LVLU 36.3K
- Earning Date
- STTK 02-27-2025
- LVLU 03-05-2025
- Dividend Yield
- STTK N/A
- LVLU N/A
- EPS Growth
- STTK N/A
- LVLU N/A
- EPS
- STTK N/A
- LVLU N/A
- Revenue
- STTK $6,435,000.00
- LVLU $324,699,000.00
- Revenue This Year
- STTK $313.04
- LVLU N/A
- Revenue Next Year
- STTK N/A
- LVLU $1.72
- P/E Ratio
- STTK N/A
- LVLU N/A
- Revenue Growth
- STTK 382.75
- LVLU N/A
- 52 Week Low
- STTK $0.94
- LVLU $0.92
- 52 Week High
- STTK $11.76
- LVLU $2.13
- Technical
- Relative Strength Index (RSI)
- STTK 44.36
- LVLU 33.67
- Support Level
- STTK $1.13
- LVLU $0.92
- Resistance Level
- STTK $1.22
- LVLU $1.03
- Average True Range (ATR)
- STTK 0.11
- LVLU 0.09
- MACD
- STTK -0.01
- LVLU -0.01
- Stochastic Oscillator
- STTK 15.15
- LVLU 4.93
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.